Literature DB >> 21592418

Transient Horner syndrome following epidural anesthesia for labor: case report and review of the literature.

Ramez Barbara1, Riad Tome, Ankur Barua, Adel Barbara, Luis Gaitini, Marwan Odeh, Hanna Garzozi.   

Abstract

UNLABELLED: Epidural anesthesia is a widely used method for pain control during labor; nevertheless, it is not without risks. Horner syndrome is an uncommon related complication. We report a case of transient Horner syndrome following epidural anesthesia and a review of the literature. We discuss the pathophysiologic and contributing factors to this syndrome and its potential complications. TARGET AUDIENCE: Obstetricians & gynecologists, family physicians. LEARNING
OBJECTIVES: After completion of this activity, physicians will be able to educate healthcare professionals working on the labor ward to be able to estimate the small incidence of Horner Syndrome following epidural anesthesia administered in labor. This will result in optimal management and will minimize the need for costly and inappropriate diagnostic investigations. The reader will also be able to compare the difference in the incidence of Horner syndrome following epidural anesthesia, as reported in the literature; appraise the clinical presentation, the pathophysiology, and the mechanism of Horner syndrome developing as a complication of regional anesthesia; and analyze the different theories proposed in the reported cases in the literature.

Entities:  

Mesh:

Year:  2011        PMID: 21592418     DOI: 10.1097/OGX.0b013e31821d6e5c

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  2 in total

1.  Unilateral Horner Syndrome Following Epidural Anaesthesia in a Morbidly Obese Parturient.

Authors:  Canan Yılmaz; Derya Karasu; Demet Özer; Ümit Çağlayan; Oya Karakaş
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-02-16

2.  Harlequin syndrome induced by intraspinal analgesia in patients with advanced cancer: a case report.

Authors:  Rong Yan; Chengxue Dang; Wei Yuan
Journal:  Transl Cancer Res       Date:  2022-07       Impact factor: 0.496

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.